| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/17/1991 | EP0437030A2 4-Substituted imidazoles for lowering intraocular pressure |
| 07/17/1991 | EP0437026A2 Use of tandospirone in the treatment of depression |
| 07/17/1991 | EP0437025A2 Compositions containing aldose reductase inhibitors for the treatment of ulcers |
| 07/17/1991 | EP0437016A2 Lipid A analogues having immunoactivating and anti-tumour activity |
| 07/17/1991 | EP0436936A2 Lipid selective anti-oxidants, their production and use |
| 07/17/1991 | EP0436935A1 A novel antibiotic Alisamycin a process for its production and its use |
| 07/17/1991 | EP0436911A2 Novel vitamin E derivatives and process for the production thereof |
| 07/17/1991 | EP0436902A1 5-Fluorouracil derivatives |
| 07/17/1991 | EP0436851A1 Compounds active as inhibitors of the enzyme HMG-CoA reductase and pharmaceutical compositions containing them |
| 07/17/1991 | EP0436831A2 Imidazo[1,2-a]pyridinylalkyl compounds for treatment of neurotoxic injury |
| 07/17/1991 | EP0436729A1 Microcapsule, treatment liquid containing microcapsules, and textile structure having microcapsules stuck thereto |
| 07/17/1991 | EP0436726A1 Method of photostabilizing eyewash |
| 07/17/1991 | EP0436682A1 Sterols, esters with fatty acids and glucosides of such sterols; a method of preparation thereof; spontaneously dispersable agents containing these compounds; and the use of such agents to treat tumours. |
| 07/17/1991 | EP0436650A1 Hydrated lipidic lamellar phases or liposomes based on ecdysteroids. |
| 07/17/1991 | EP0436631A1 Method and composition for the treatment of burns. |
| 07/17/1991 | EP0436612A1 Amino acid transport proteins, amino acid analogues, assay apparatus, uses thereof for treatment and diagnosis of cancer |
| 07/17/1991 | EP0436611A1 Compound and method for the retardation of collagen cross-linking |
| 07/17/1991 | EP0436568A1 Dihydroxyaryl 4-substituted monocarbams as antibiotics |
| 07/17/1991 | CN1053090A Process for preparing mixture of ribonucleotides |
| 07/17/1991 | CN1053067A Method for preparation and purification of mixture of glycosphingolipids free from contamination by non-conventional viruses |
| 07/17/1991 | CN1053066A 3-deoxy mycaminosyl tylonlide derivatives |
| 07/17/1991 | CN1053065A Azaoxindole derivatives |
| 07/17/1991 | CN1053064A Process for preparing heterocyclic derivatives |
| 07/17/1991 | CN1053063A Quinazoline derivatives and their preparation |
| 07/17/1991 | CN1053062A Vitamin e derivatives and process for preparing them |
| 07/17/1991 | CN1053060A 3-aminopiperidine derivatives and related nitrogen containing heterocycles |
| 07/17/1991 | CN1053059A Polyamines useful as antagonists of excitatory amino acid neurotrans-mitters |
| 07/17/1991 | CN1053058A Method for refining industrial synthesized glycine into medicinal glycine |
| 07/17/1991 | CN1053054A Process for preparing halogenated olefine and uses as pesticide and acaricide thereof |
| 07/17/1991 | CN1053010A Pharmaceutical preparation |
| 07/17/1991 | CN1013198B Anti-tumour sulfonylurea deriv. preparing process |
| 07/17/1991 | CN1013196B Benzoyl urea compounds producing process |
| 07/17/1991 | CA2048627A1 1,4,10,13-tetraoxa-7,16-diazacyclooctadecane derivatives, pharmaceutical compositions containing them and their use for the removal of toxic metal ions and radioactive isotopes from the living organism |
| 07/17/1991 | CA2034206A1 Di(nitroxyalkyl)amides of pyridine-2,4- and -2,5-dicarboxylic acids, a process for the preparation thereof, and the use thereof |
| 07/16/1991 | WO1991010663A1 2,13-disubstituted ergolins, their preparation and their use in drugs |
| 07/16/1991 | US5032679 Heparin fragments as inhibitors of smooth muscle cell proliferation |
| 07/16/1991 | US5032617 Substituted benzamide radiosensitizers |
| 07/16/1991 | US5032614 Vasodilator |
| 07/16/1991 | US5032613 Method and composition for treating arthritis |
| 07/16/1991 | US5032612 Non-smoking aid |
| 07/16/1991 | US5032610 Activity against carcinoma and method for the treatment of carcinoma |
| 07/16/1991 | US5032609 Ethanolamine derivatives |
| 07/16/1991 | US5032608 Method and substrate composition for treating atherosclerosis |
| 07/16/1991 | US5032607 Use of olefinic compounds |
| 07/16/1991 | US5032604 Class III antiarrhythmic agents |
| 07/16/1991 | US5032603 Medicaments |
| 07/16/1991 | US5032602 Inhibiting HMG-CoA reductase with novel substituted 2-pyridones and pyrid-2-thiones |
| 07/16/1991 | US5032601 Cardiovascular disorders |
| 07/16/1991 | US5032600 Alkyl diamine derivatives |
| 07/16/1991 | US5032598 Nitrogens containing heterocyclic compounds as class III antiarrhythmic agents |
| 07/16/1991 | US5032596 Hypotensive |
| 07/16/1991 | US5032595 Method of stimulating steroidogenesis with alpidem |
| 07/16/1991 | US5032594 Tricyclic fused pyrimidine derivatives, their production and use |
| 07/16/1991 | US5032593 Method of treating bronchoconstriction with 1,3-unsymmetrical straight chain alkyl-substituted 8-phenylxanthines |
| 07/16/1991 | US5032592 Alkene, alkyne or cycloalkylene derivatives |
| 07/16/1991 | US5032591 Hypotensive |
| 07/16/1991 | US5032590 Substituted hydroxylamines |
| 07/16/1991 | US5032586 Enzyme inhibitors, steroid hormones |
| 07/16/1991 | US5032585 Antiulcer, respiratory system disorders |
| 07/16/1991 | US5032584 S-diastereomer of an n6 -((2-hydroxypropyl)aryl)adenosine and its medicinal uses |
| 07/16/1991 | US5032583 Cardiovascular disorders |
| 07/16/1991 | US5032581 Tylosin derivatives |
| 07/16/1991 | US5032580 Viricides |
| 07/16/1991 | US5032579 Method for inhibiting the growth of salmonella |
| 07/16/1991 | US5032578 Method for preventing or treating depression employing a combination of an ace inhibitor and a drug that acts at serotonin receptors |
| 07/16/1991 | US5032577 Peptidylaminodiols |
| 07/16/1991 | US5032575 Epidermal growth factor or homolog thereof |
| 07/16/1991 | US5032505 Inhibitors for glycosaminosyl transferase V |
| 07/16/1991 | US5032408 Paraffin oil, glycerides, pancreas or thymus extreact, quaternized montmorillonite, preservative |
| 07/16/1991 | US5032406 Sustained release |
| 07/16/1991 | US5032404 Fungicides |
| 07/16/1991 | US5032394 Ethylene oxide-propylene oxide copolymer |
| 07/16/1991 | US5032393 Ranitidine flavor masking |
| 07/16/1991 | US5032392 Vitamin A, antioxidant, chelate agent |
| 07/16/1991 | US5032384 Tocopherol and ketoprofen, peridontal diseases |
| 07/16/1991 | US5032311 Detergent composition containing polianthes L-derived acidic heteropolysaccharide |
| 07/16/1991 | CA2049016A1 2,13-disubstituted ergolines, their production and use in pharmaceutical agents |
| 07/16/1991 | CA2034016A1 Compounds |
| 07/16/1991 | CA2032377A1 Imidazolyl propyl guanidine derivative, a process for its preparation and a pharmaceutical composition containing this compound |
| 07/16/1991 | CA1286313C OCULOSELECTIVE .beta.-BLOCKERS |
| 07/16/1991 | CA1286309C Ester derivative of substituted acetic acid and preparing the same |
| 07/16/1991 | CA1286304C Substituted azetidinones as anti-inflammatory and antidegenerative agents |
| 07/16/1991 | CA1286301C 2,2'-bi-1h-imidazoles |
| 07/16/1991 | CA1286300C 5-(1-cyano-n-methyl-n-phenethyl)-alkylamino-2,2-8-trimethyl -4h-dioxino-¬4,5-c|-pyridine derivatives |
| 07/16/1991 | CA1286294C Substituted aromatic sulfonamides as antiglaucoma agents |
| 07/16/1991 | CA1286292C Medicaments, vicinal dihydroxyalkylxanthines contained therein, process for the preparation of these xanthine compounds and intermediate products suitable for these |
| 07/16/1991 | CA1286290C Anti-allergic pyrimido[2,1-l-b]benzothiazoles |
| 07/16/1991 | CA1286288C Diels-alder adduct from streptazoline and naphthoquinones andits oxidation products, a process for their preparation and their use |
| 07/16/1991 | CA1286286C Process for producing natural heparan sulphate and dermatan sulphate in substantially pure form, and their pharmaceutical use |
| 07/16/1991 | CA1286285C Stable hydrate of penicillin derivative and process for preparing same |
| 07/16/1991 | CA1286229C Pseudoephedrine dosage form |
| 07/16/1991 | CA1286228C Use of xanthine derivatives for host defense mechanism enhancement |
| 07/16/1991 | CA1286227C Externally applicable, antiviral pharmaceutical composition accumulating in the skin and process for the preparation of same |
| 07/16/1991 | CA1286225C Medicament for the treatment of inflammations of the eye |
| 07/14/1991 | WO1991010432A1 Ataractic |
| 07/14/1991 | CA2073464A1 Anxiolytic drugs |
| 07/13/1991 | WO1991010662A1 2-substituted 4,5-diphenyl-imidazoles |
| 07/13/1991 | WO1991010646A1 1-azetidyl and 1-hexamethylenimine alkyl or aryl bisphosphonic acids and their use as pharmacological agents |
| 07/13/1991 | WO1991010644A1 Cycloalkyl-substituted glutaramide diuretic agents |
| 07/13/1991 | WO1991010433A1 4,4'-[9h-fluoren-9-ylidenebis(methylene)]-bispyrimidine for treating neurological disorders |